Evidence map›Paper›PMID 27505895›Full record

ArticleJournal of cell science2016

Gα12 is required for renal cystogenesis induced by Pkd1 inactivation.

Yong Wu, Jen X Xu, Wassim El-Jouni, Tzongshi Lu, Suyan Li, Qingyi Wang, Mei Tran, Wanfeng Yu, Maoqing Wu, Ivan E Barrera and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Notch2 Inhibition and Kidney Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Mechanism of tethered agonist-mediated signaling by polycystin-1.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. The GPCR properties of polycystin-1- A new paradigm.Frontiers in molecular biosciences · 2022
    Review
  9. GαFrontiers in cell and developmental biology · 2022
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Hippo signaling-a central player in cystic kidney disease?Pediatric nephrology (Berlin, Germany) · 2020
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Yong WuRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-6770-1328
Jen X XuRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-4908-9459
Wassim El-JouniRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-2266-2171
Tzongshi LuRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-4472-752X
Suyan LiRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-2304-0219
Qingyi WangRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-9435-9510
Mei TranRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA Renal Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Wanfeng YuRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-3401-0023
Maoqing WuRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Ivan E BarreraRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-8232-7589
Joseph V BonventreRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Jing ZhouRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Bradley M DenkerRenal Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.ORCID 0000-0002-8137-1043
Tianqing KongRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA tqkong@gmail.com.ORCID 0000-0001-8634-3423
Brigham and Women's Hospital · USBeth Israel Deaconess Medical Center · US

Funding

Research BaseP30DK090868 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2010 to 2019
$11.1M
KIDNEY INJURY MOLECULE-1 IN EPITHELIAL REPAIRR01DK072381 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2025
$8.6M
Polycystin channels and calciumP50DK074030 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, JING · 2005 to 2009
$5.9M
Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
Mouse model of polycystic kidney diseaseR37DK051050 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, JING · 2005 to 2014
$4.2M
Attachment, Targeting &Localization of Galpha SubunitsR01GM055223 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DENKER, BRADLEY M · 2002 to 2010
$2.8M
MODEL OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASER01DK051050 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, JING · 1995 to 2004
$2.0M
Polycystin-1 Regulation of Galpha 12 and Integrins in Polycystic Kidney DiseaseK01DK080179 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI KONG, TIANQING · 2008 to 2012
$813k
Cell biology of autosomal dominant polycystic kidney diseaseR01DK099532 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, JING · 2014 to 2016
$796k
ATTACHMENT, TARGETING &LOCALIZATION OF G ALPHA SUBUNITR29GM055223 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DENKER, BRADLEY M · 1997 to 2001
$237k
Complement C3 is Essential for Development of Kidney Cysts in ADPKD MiceR03DK096160 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI KONG, TIANQING · 2013 to 2014
$158k
NIDDK NIH HHS K01 DK080179NIDDK NIH HHS P30 DK090868NIDDK NIH HHS P50 DK074030NIDDK NIH HHS R01 DK051050NIDDK NIH HHS R01 DK072381NIDDK NIH HHS R01 DK099532NIDDK NIH HHS R03 DK096160NIDDK NIH HHS R37 DK039773NIDDK NIH HHS R37 DK051050NIGMS NIH HHS R01 GM055223NIGMS NIH HHS R29 GM055223
6 · The paper itself

Abstract

Mutation of PKD1, encoding the protein polycystin-1 (PC1), is the main cause of autosomal dominant polycystic kidney disease (ADPKD). The signaling pathways downstream of PC1 in ADPKD are still not fully understood. Here, we provide genetic evidence for the necessity of Gα12 (encoded by Gna12, hereafter Gα12) for renal cystogenesis induced by Pkd1 knockout. There was no phenotype in mice with deletion of Gα12 (Gα12

Indexed as

AnimalsCadherinsCell-Matrix JunctionsEpithelial CellsGene DeletionGene Knockout TechniquesGTP-Binding Protein alpha Subunits, G12-G13KidneyLiverMiceModels, BiologicalPolycystic Kidney, Autosomal DominantStress FibersTRPP Cation ChannelsCadherinsGTP-Binding Protein alpha Subunits, G12-G13TRPP Cation Channelsand Polycystic kidney diseasesCadherinG proteinsPolycystin-1

Identifiers

PMID27505895
PMCPMC5087651
OpenAlexW2480686207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.